Eurobio Scientific UK

Eurobio Scientific UK provides specialist diagnostic solutions to clinical laboratories across the UK and Ireland, with a strong focus on Infectious Disease and Infection Prevention & Control. Our portfolio includes molecular diagnostics, serology platforms, and advanced sequencing technologies that support faster and more accurate diagnosis. Key solutions include EurobioPlex® Dermascreen and Dermatyping for dermatological infections, AutoDAT for semi-automated seroagglutination testing, CubeDx for rapid pathogen detection in suspected sepsis directly from whole blood, and DeepChek® HIV NGS testing, which enables HIV genotyping and detection of antiretroviral drug-resistance mutations to support personalised treatment strategies.

Approach to Healthcare:

Eurobio Scientific UK supports clinical laboratories with practical diagnostic solutions that help improve patient care. In infectious disease, our focus is on enabling faster and more accurate identification of pathogens so clinicians can make treatment decisions sooner. Our portfolio combines molecular diagnostics, serology platforms, and rapid pathogen detection technologies designed to support routine testing and critical care settings. By working closely with laboratories and understanding their day-to-day challenges, we aim to provide reliable technologies that strengthen infection prevention, support antimicrobial stewardship, and improve patient outcomes.

Impact of Products/Services on Healthcare:

Our diagnostic solutions help laboratories identify infectious pathogens more quickly and accurately, enabling earlier and more targeted treatment for patients. Technologies such as rapid pathogen detection for sepsis, multiplex molecular assays for dermatological infections, and advanced HIV drug-resistance testing support clinicians in making informed decisions sooner. By improving diagnostic speed and reliability, our products help laboratories streamline workflows, strengthen infection prevention and control, and support antimicrobial stewardship within healthcare systems.

Innovation:

Eurobio Scientific UK continues to expand its infectious disease diagnostics portfolio through the introduction of innovative molecular and rapid diagnostic technologies. One key example is CubeDx technology, which enables rapid pathogen detection directly from whole blood in around three hours, supporting earlier diagnosis of sepsis and enabling faster clinical intervention in critically ill patients.

We have also introduced EurobioPlex® Dermatyping, a multiplex molecular assay designed for the identification and characterisation of pathogens causing dermatological infections.

In addition, DeepChek® HIV drug-resistance testing supports HIV genotyping using next-generation sequencing platforms including Illumina and Oxford Nanopore, enabling laboratories to detect resistance mutations and support personalised treatment strategies.

Future Direction:

Eurobio Scientific UK will continue to invest in innovative technologies that improve the diagnosis and management of infectious diseases. Our focus is on bringing specialised diagnostic solutions to laboratories that enable faster pathogen detection and earlier treatment decisions. By supporting earlier diagnosis and better clinical insight, we aim to help healthcare providers improve patient outcomes and ultimately save lives.